Maturation-Resistant Dendritic Cells Ameliorate Experimental Autoimmune Uveoretinitis
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Endogenous uveitis is a chronic inflammatory eye disease of human, which frequently leads to blindness. Experimental autoimmune uveoretinitis (EAU) is an animal disease model of human endogenous uveitis and can be induced in susceptible animals by immunization with retinal antigens. EAU resembles the key immunological characteristics of human disease in that both are CD4^+ T-cell mediated diseases. Dendritic cells (DCs) are specialized antigen-presenting cells that are uniquely capable of activating naïve T cells. Regulation of immune responses through modulation of DCs has thus been tried extensively. Recently our group reported that donor strain-derived immature DC pretreatment successfully controlled the adverse immune response during allogeneic transplantation. Methods: EAU was induced by immunization with human interphotoreceptor retinoid-binding protein (IRBP) peptide1-20. Dendritic cells were differentiated from bone marrow in the presence of recombinant GM-CSF. Results: In this study, we used paraformaldehyde-fixed bone marrow-derived DCs to maintain them in an immature state. Pretreatment with fixed immature DCs, but not fixed mature DCs, ameliorated the disease progression of EAU by inhibiting uveitogenic CD4^+ T cell activation and differentiation. Conclusion: Application of iBMDC prepared according to the protocol of this study would provide an important treatment modality for the autoimmune diseases and transplantation rejection.
Abstract
Background: Endogenous uveitis is a chronic inflammatory eye disease of human, which frequently leads to blindness. Experimental autoimmune uveoretinitis (EAU) is an animal disease model of human endogenous uveitis and can be induced in susceptible animals by immunization with retinal antigens. EAU resembles the key immunological characteristics of human disease in that both are CD4^+ T-cell mediated diseases. Dendritic cells (DCs) are specialized antigen-presenting cells that are uniquely capable of activating naïve T cells. Regulation of immune responses through modulation of DCs has thus been tried extensively. Recently our group reported that donor strain-derived immature DC pretreatment successfully controlled the adverse immune response during allogeneic transplantation. Methods: EAU was induced by immunization with human interphotoreceptor retinoid-binding protein (IRBP) peptide1-20. Dendritic cells were differentiated from bone marrow in the presence of recombinant GM-CSF. Results: In this study, we used paraformaldehyde-fixed bone marrow-derived DCs to maintain them in an immature state. Pretreatment with fixed immature DCs, but not fixed mature DCs, ameliorated the disease progression of EAU by inhibiting uveitogenic CD4^+ T cell activation and differentiation. Conclusion: Application of iBMDC prepared according to the protocol of this study would provide an important treatment modality for the autoimmune diseases and transplantation rejection.
참고문헌 (21)
- Ahn JK, "CD8brightCD56+T cells are cytotoxic effectors in patients with active Behcet's uveitis", J Immunol, 175, pp.6133~6142 (2005)
- Yu HG, "The number of CD8+ T cells and NKT cells increases in the aqueous humor of patients with Behçet's uveitis", Clin Exp Immunol, 137, pp.437~443 (2004)
- Caspi RR, "The mouse as a model of experimental autoimmune uveoretinitis (EAU)", Curr Eye Res, 9, pp.169~174 (1990)
- Nussenblatt RB, "Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen", J Immunol, 144, pp.1689~1695 (1990)
- Sun B, "Genetic susceptibility to experimental autoimmune uveitis involves more than a predisposition to generate a T helper-1-like or a T helper-2-like response", J Immunol, 159, pp.1004~1011 (1997)
- Turley SJ, "Dendritic cells: inciting and inhibiting autoimmunity", Curr Opin Immunol, 14, pp.765~770 (2002)
- O'Connell PJ, "Immature and mature CD8alpha+ dendritic cells prolong the survival of vascularized heart allografts", J Immunol, 168, pp.143~154 (2002)
- Steinman RM, "Tolerogenic dendritic cells", Annu Rev Immunol, 21, pp.685~711 (2003)
- Wakkach A, "Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo", Immunity, 18, pp.605~617 (2003)
- Adorini L, "Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting autoimmune diabetes", Ann N Y Acad Sci, 987, pp.258~261 (2003)
- Roelen DL, "Prolongation of skin graft survival by modulation of the alloimmune response with alternatively activated dendritic cells", Transplantation, 76, pp.1608~1615 (2003)
- Raimondi G, "Dendritic cells, tolerance and therapy of organ allograft rejection", Contrib Nephrol, 146, pp.105~120 (2005)
- Kang HG, "Donor-strain-derived immature dendritic cell pre-treatment induced hyporesponsiveness against allogeneic antigens", IMMUNOLOGY, 129, pp.567~577, BLACKWELL PUBLISHING
- Oh K, "Invariant NKT cells regulate experimental autoimmune uveitis through inhibition of Th17 differentiation", EUROPEAN JOURNAL OF IMMUNOLOGY, 41(2), pp.392~402, WILEY-V C H VERLAG GMBH
- Chan CC, "Pathology of experimental autoimmune uveoretinitis in mice", J Autoimmun, 3, pp.247~255 (1990)
- Sun B, "Genetic susceptibility to experimental autoimmune uveitis involves more than a predisposition to generate a T helper-1-like or a T helper-2-like response", J Immunol, 159, pp.1004~1011 (1997)
- Amadi-Obi A, "TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27", STAT1, 2007, pp.13, 711~718
- Tang J, "Autoimmune uveitis elicited with antigen-pulsed dendritic cells has a distinct clinical signature and is driven by unique effector mechanisms: initial encounter with autoantigen defines disease phenotype", J Immunol, 178, pp.5578~5587 (2007)
- Luger D, "Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category", J Exp Med, 205, pp.799~810 (2008)
- Gregori S, "Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance", J Immunol, 167, pp.1945~1953 (2001)
- Hayamizu K, "Monocyte-derived dendritic cell precursors facilitate tolerance to heart allografts after total lymphoid irradiation", Transplantation, 66, pp.1285~1291 (1998)